A Multicentre, Double Blind, Randomized Placebo Controlled Trial to Assess the Effect of LF-PB on Seroma Formation in Women With Breast Cancer Undergoing Axillary Lymph Node Dissection
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2017
At a glance
- Drugs Octreotide (Primary)
- Indications Inflammation; Seroma
- Focus Therapeutic Use
- Sponsors CHEMI S.p.A.
- 01 Feb 2017 Status changed from active, no longer recruiting to completed.
- 15 Jun 2016 Planned End Date changed from 1 Jan 2017 to 1 Aug 2016.
- 15 Jun 2016 Status changed from recruiting to active, no longer recruiting.